These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 29031169)

  • 41. Novel thiobarbiturates as potent urease inhibitors with potential antibacterial activity: Design, synthesis, radiolabeling and biodistribution study.
    Abdulwahab HG; Harras MF; El Menofy NG; Hegab AM; Essa BM; Selim AA; Sakr TM; El-Zahabi HSA
    Bioorg Med Chem; 2020 Dec; 28(23):115759. PubMed ID: 32992246
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Synthesis, Antioxidant and In-Silico Studies of Potent Urease Inhibitors: N-(4-{[(4-Methoxyphenethyl)-(substituted)amino]sulfonyl}phenyl)acetamides.
    Abbasi MA; Raza H; Rehman AU; Siddiqui SZ; Nazir M; Mumtaz A; Shah SAA; Seo SY; Hassan M
    Drug Res (Stuttg); 2019 Feb; 69(2):111-120. PubMed ID: 30086567
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Jack Bean Urease Inhibitors, and Antioxidant Activity Based on Palmitic acid Derived 1-acyl-3- Arylthioureas: Synthesis, Kinetic Mechanism and Molecular Docking Studies.
    Saeed A; Ur-Rehman S; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Drug Res (Stuttg); 2017 Oct; 67(10):596-605. PubMed ID: 28672409
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A facile one-pot synthesis of 2-arylamino-5-aryloxylalkyl-1,3,4-oxadiazoles and their urease inhibition studies.
    Akhtar T; Khan MA; Iqbal J; Jones PG; Hameed S
    Chem Biol Drug Des; 2014 Jul; 84(1):92-8. PubMed ID: 24495281
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Synthesis and Studies of Fluorescein Based Derivatives for their Optical Properties, Urease Inhibition and Molecular Docking.
    Mahajan PG; Dige NC; Vanjare BD; Raza H; Hassan M; Seo SY; Hong SK; Lee KH
    J Fluoresc; 2018 Nov; 28(6):1305-1315. PubMed ID: 30220013
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Synthesis, structure-activity relationship analysis and kinetics study of reductive derivatives of flavonoids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; He J; Ouyang H; Feng YT; Lu CL; Lin WQ; Wang JX; Xiang YP; Zhu HL
    Eur J Med Chem; 2013 May; 63():685-95. PubMed ID: 23567958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Synthesis of
    Iqbal S; Khan A; Nazir R; Kiran S; Perveen S; Khan KM; Choudhary MI
    Med Chem; 2020; 16(2):244-255. PubMed ID: 30987574
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Synthesis of diindolylmethane (DIM) bearing thiadiazole derivatives as a potent urease inhibitor.
    Taha M; Rahim F; Khan AA; Anouar EH; Ahmed N; Shah SAA; Ibrahim M; Zakari ZA
    Sci Rep; 2020 May; 10(1):7969. PubMed ID: 32409737
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hybrid Pharmacophoric Approach in the Design and Synthesis of Coumarin Linked Pyrazolinyl as Urease Inhibitors, Kinetic Mechanism and Molecular Docking.
    Saeed A; Mahesar PA; Channar PA; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Chem Biodivers; 2017 Aug; 14(8):. PubMed ID: 28574649
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthesis, biological evaluation, and molecular docking studies of 2,5-substituted-1,4-benzoquinone as novel urease inhibitors.
    You ZL; Xian DM; Zhang M; Cheng XS; Li XF
    Bioorg Med Chem; 2012 Aug; 20(16):4889-94. PubMed ID: 22824761
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Benzylidine indane-1,3-diones: As novel urease inhibitors; synthesis, in vitro, and in silico studies.
    Bano B; Kanwal ; Khan KM; Begum F; Lodhi MA; Salar U; Khalil R; Ul-Haq Z; Perveen S
    Bioorg Chem; 2018 Dec; 81():658-671. PubMed ID: 30253339
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, X-ray molecular structure, biological evaluation and molecular docking studies of some N
    Pervez H; Khan N; Zaib S; Yaqub M; Naseer MM; Tahir MN; Iqbal J
    Bioorg Med Chem; 2017 Feb; 25(3):1022-1029. PubMed ID: 28011200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Design, synthesis, molecular docking, anti-Proteus mirabilis and urease inhibition of new fluoroquinolone carboxylic acid derivatives.
    Abdullah MA; Abuo-Rahma GE; Abdelhafez EM; Hassan HA; Abd El-Baky RM
    Bioorg Chem; 2017 Feb; 70():1-11. PubMed ID: 27908539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isoindolin-1-one derivatives as urease inhibitors: Design, synthesis, biological evaluation, molecular docking and in-silico ADME evaluation.
    Peytam F; Adib M; Mahernia S; Rahmanian-Jazi M; Jahani M; Masoudi B; Mahdavi M; Amanlou M
    Bioorg Chem; 2019 Jun; 87():1-11. PubMed ID: 30852231
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Sulfonamide-Linked Ciprofloxacin, Sulfadiazine and Amantadine Derivatives as a Novel Class of Inhibitors of Jack Bean Urease; Synthesis, Kinetic Mechanism and Molecular Docking.
    Channar PA; Saeed A; Albericio F; Larik FA; Abbas Q; Hassan M; Raza H; Seo SY
    Molecules; 2017 Aug; 22(8):. PubMed ID: 28813027
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Design, synthesis, molecular docking studies and in vitro screening of ethyl 4-(3-benzoylthioureido) benzoates as urease inhibitors.
    Saeed A; Khan MS; Rafique H; Shahid M; Iqbal J
    Bioorg Chem; 2014 Feb; 52():1-7. PubMed ID: 24269986
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Therapeutic potential of N
    Islam M; Khan A; Shehzad MT; Khiat M; Halim SA; Hameed A; Shah SR; Basri R; Anwar MU; Hussain J; Csuk R; Al-Harrasi A; Shafiq Z
    Bioorg Chem; 2021 Apr; 109():104691. PubMed ID: 33601138
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ferrocene-based guanidine derivatives: in vitro antimicrobial, DNA binding and docking supported urease inhibition studies.
    Gul R; Rauf MK; Badshah A; Azam SS; Tahir MN; Khan A
    Eur J Med Chem; 2014 Oct; 85():438-49. PubMed ID: 25108360
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Synthesis, biological assay in vitro and molecular docking studies of new Schiff base derivatives as potential urease inhibitors.
    Aslam MA; Mahmood SU; Shahid M; Saeed A; Iqbal J
    Eur J Med Chem; 2011 Nov; 46(11):5473-9. PubMed ID: 21981981
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.